Abstract

Recent meta-analyses report that vitamin D supplementation increases blood fibroblast growth factor-23 (FGF23) level. To determine the effect of 4000IU/day of vitamin D3 for 12months on circulating FGF23 levels. We also examined the association of the achieved 25-hydroxyvitamin D level [25(OH)D] with the FGF23 level at 12months and with 12-month changes in FGF23. An ancillary analysis among adults 70years and older with prediabetes who participated in a trial comparing vitamin D3 4000IU/day with placebo. Plasma intact FGF23 and serum 25(OH)D were measured at baseline and month 12 (M12). Characteristics of the 52 participants (vitamin D3 n = 28; placebo n = 24) did not differ significantly aside from more women than men in the vitamin D3 group. Mean ± SD age was 73.8 ± 3.7years, BMI 31.3 ± 4.2kg/m2, and glomerular filtration rate (GFR) 76.3 ± 11.8mL/min/1.73m2 Baseline serum 25(OH)D level was 33.4 ± 10.8ng/mL and increased at M12 to 54.9 ± 14.8ng/mL in the vitamin D3 group versus 33.4 ± 14.9 in the placebo (p < 0.001). At baseline, GFR was inversely associated with FGF23 (r = -0.349, p = 0.011). Change in FGF23 level at M12 did not differ significantly between vitamin D3 and placebo. In all participants combined, the achieved serum 25(OH)D level at M12 was not significantly associated with the M12 plasma FGF23 or the M12 change in FGF23. In obese older adults with sufficient vitamin D status and normal renal function, vitamin D3 4000IU/day for 12months did not significantly alter plasma intact FGF23 levels. gov NCT 01,942,694, registered 9/16/2013.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.